Panthera News - Panthera Clinical Trials

Abstract purple gradient background

Speeding up trial enrolment can save billions

Abstract purple gradient background

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

A group of men and women in corporate team

Panthera partnership with Preston North End Community Trust

Dr Amir Afzul and a patient

Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine to volunteers in COVID prevention study

Purple Panthera branded background graphic

Clinical trial specialist Panthera Biopartners has appointed corporate financier Christopher Steed as a non-executive director to continue its expansion both in the UK and overseas

Man speaking in meeting room

Panthera adapts for COVID-19 virus – Letter from Stuart Young, CEO

1 2 3 4

Ready to take part?

Join this trial and help shape future treatments today

Register for trials